FDA Approves First Therapy for Rare Pediatric Immune Disorder FDA Approves First Therapy for Rare Pediatric Immune Disorder
Prior to this approval, patients with congenital athymia, a condition where a child is born without a thymus, only received supportive care.Medscape Medical News
Source: Medscape Transplantation Headlines - Category: Transplant Surgery Tags: Allergy & Clinical Immunology News Source Type: news
More News: Allergy | Allergy & Immunology | Children | Pediatrics | Transplant Surgery | Transplants